27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares dropped 5.3 percent to touch a new 52-week low of $7.72. Oncomed Pharmaceuticals shares have dropped 60.72 percent over the past 52 weeks, while the S&P 500 index has gained 8.61 percent in the same period.
- Gilead Sciences, Inc. (NASDAQ: GILD) shares reached a new 52-week low of $71.32. Gilead disclosed that it has submitted a New Drug Application to the FDA for sofosbuvir.
- Juno Therapeutics Inc (NASDAQ: JUNO) shares touched a new 52-week low of $18.33. Juno Therapeutics shares have declined 61.48 percent over the past 52 weeks, while the S&P 500 index has gained 8.61 percent in the same period.
- Aradigm Corporation (NASDAQ: ARDM) shares reached a new 52-week low of $2.07. Aradigm shares have dropped 48.22 percent over the past 52 weeks, while the S&P 500 index has gained 8.61 percent in the same period.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!